370 related articles for article (PubMed ID: 16192724)
1. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease.
Wiltshire K; Foster S; Kaye JA; Small BJ; Camicioli R
Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Hayashi T; Oyanagi C; Konishi J; Shio H
J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614
[TBL] [Abstract][Full Text] [Related]
3. Does the pattern of atrophy of the Corpus callosum differ between patients with frontotemporal dementia and patients with Alzheimer's disease?
Hensel A; Ibach B; Muller U; Kruggel F; Kiefer M; Gertz HJ
Dement Geriatr Cogn Disord; 2004; 18(1):44-9. PubMed ID: 15084793
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
6. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
8. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
9. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.
Grossman M; McMillan C; Moore P; Ding L; Glosser G; Work M; Gee J
Brain; 2004 Mar; 127(Pt 3):628-49. PubMed ID: 14761903
[TBL] [Abstract][Full Text] [Related]
10. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
11. [Is hippocampal atrophy a specific change for Alzheimer's disease?].
Hanyu H; Asano T; Sakamoto S; Kogure D; Iwamoto T; Takasaki M
No To Shinkei; 1999 Nov; 51(11):947-51. PubMed ID: 10586410
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease is associated with hippocampal atrophy.
Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
[TBL] [Abstract][Full Text] [Related]
13. Regional atrophy of the corpus callosum in dementia.
Hallam BJ; Brown WS; Ross C; Buckwalter JG; Bigler ED; Tschanz JT; Norton MC; Welsh-Bohmer KA; Breitner JC
J Int Neuropsychol Soc; 2008 May; 14(3):414-23. PubMed ID: 18419840
[TBL] [Abstract][Full Text] [Related]
14. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.
Bocti C; Rockel C; Roy P; Gao F; Black SE
Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
16. Frontal corpus callosum alterations in progressive supranuclear palsy but not in Parkinson's disease.
Rosskopf J; Müller HP; Huppertz HJ; Ludolph AC; Pinkhardt EH; Kassubek J
Neurodegener Dis; 2014; 14(4):184-93. PubMed ID: 25377379
[TBL] [Abstract][Full Text] [Related]
17. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
[TBL] [Abstract][Full Text] [Related]
18. Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease.
Gootjes L; Bouma A; Van Strien JW; Van Schijndel R; Barkhof F; Scheltens P
Neuropsychologia; 2006; 44(2):208-17. PubMed ID: 15955540
[TBL] [Abstract][Full Text] [Related]
19. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease.
Kabay SC; Gulbandilar E; Ozden H; Ozbag D; Guven G; Adapinar B; Durmaz R
Neurodegener Dis; 2009; 6(4):148-53. PubMed ID: 19521062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
